TNXP Tonix Pharmaceuticals Holding Corp.companySEC Filings & Insider Trading Activity 2026
Latest Tonix Pharmaceuticals Holding Corp. (TNXP) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 12, 2026, a 10-Q quarterly report filed on November 10, 2025, an 8-K current report filed on May 1, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Tonix Pharmaceuticals Holding Corp. (TNXP) (SEC CIK 1430306), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Tonix Pharmaceuticals Holding Corp. (TNXP) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | May 1, 2026 | — | — | — |
8-K | Apr 29, 2026 | — | — | — |
8-K | Apr 23, 2026 | — | — | — |
8-K | Mar 31, 2026 | — | — | — |
8-K | Mar 26, 2026 | — | — | — |
8-K | Mar 18, 2026 | — | Analysis | — |
8-K | Mar 13, 2026 | — | Analysis | — |
10-K | Mar 12, 2026 | Dec 31, 2025 | — | |
8-K | Mar 10, 2026 | — | Analysis | — |
8-K | Mar 3, 2026 | — | Analysis | — |
8-K | Feb 3, 2026 | — | — | |
8-K | Dec 29, 2025 | — | — | |
8-K | Dec 29, 2025 | — | — | |
8-K | Dec 16, 2025 | — | — | |
8-K | Dec 9, 2025 | — | — | |
8-K | Nov 24, 2025 | — | — | |
10-Q | Nov 10, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 11, 2025 | Jun 30, 2025 | — | |
10-Q | May 12, 2025 | Mar 31, 2025 | — | |
10-K | Mar 18, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 16, 2024 | Jun 30, 2024 | — | |
10-Q | May 13, 2024 | Mar 31, 2024 | — | |
10-K | Apr 1, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | — |
Frequently Asked Questions
What are the latest TNXP SEC filings in 2026?
Tonix Pharmaceuticals Holding Corp. (TNXP) has filed a 10-K annual report on March 12, 2026, a 10-Q quarterly report on November 10, 2025, an 8-K current report on May 1, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did TNXP file its most recent 10-K annual report?
Tonix Pharmaceuticals Holding Corp. (TNXP) filed its most recent 10-K annual report on March 12, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view TNXP 10-Q quarterly reports?
Tonix Pharmaceuticals Holding Corp. (TNXP)'s most recent 10-Q quarterly report was filed on November 10, 2025. SignalX displays every TNXP 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has TNXP filed recently?
Tonix Pharmaceuticals Holding Corp. (TNXP)'s most recent 8-K was filed on May 1, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find TNXP insider trading activity (Form 4)?
SignalX aggregates every TNXP Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does TNXP file with the SEC?
Tonix Pharmaceuticals Holding Corp. (TNXP) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new TNXP filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Tonix Pharmaceuticals Holding Corp. (TNXP).
What is TNXP's SEC CIK number?
Tonix Pharmaceuticals Holding Corp. (TNXP)'s SEC CIK (Central Index Key) number is 1430306. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1430306 to look up all TNXP filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find TNXP return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Tonix Pharmaceuticals Holding Corp. (TNXP) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Tonix Pharmaceuticals Holding Corp. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 51+ filings.